CVS Health Corp (CVS)
$56.62
0.08 (0.14%)
CVS Stock Quote Delayed 30 Minutes
CVS CarePass: CVS Free Delivery Program Goes Nationwide
CVS CarePass is now available across the U.S. and it offers many benefits to members that sign up for the loyalty program.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
74.71B
PE Ratio
9.93
EPS
5.7
Volume (Avg. Vol.)
6.28M
Day's Range
$55.85 - $56.74
52-Week Range
$52.77 - $83.25
Dividend & Yield
$2.42 (4.27%)
CVS Stock Predictions, Articles, and CVS Health Corp News
A Healthcare Overhaul Makes CVS Stock a Buy Despite Near-Term Uncertainty
Don't be scared away by near-term uncertainty. CVS stock makes a great long-term bet in the healthcare space if you can stomach some turbulence in the second half of 2019.
CVS Stock Bears Have Got It All Wrong
CVS stock has been a laggard for the past four years. But the company, of course, keeps trying to get things back on track. And, these moves will likely have positive long-term impacts.
Here’s The Not-So-Crazy Speculative Case for CVS Health Stock
Massive changes in the health care landscape have brought CVS stock crashing down to earth. However, CVS Health stock is one of the best names in a troubled segment.
The Worst Appears to Be Over for CVS Stock
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
CVS Stock Will Come Back Strong, but Be Wary of Upcoming Earnings
Long-term shareholders in the retail pharma giant CVS stock are likely to be rewarded handsomely
Right Now It Looks as If It Is Time for CVS Stock to Breakout Higher
The multi year sell-off in CVS stock may be coming to an end, and what comes next could be a big rally.
A Pairs Prescription for CVS Stock and Merck
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
CVS Stock Is a Buy as It Prepares to Take on Private Insurance
CVS gained cash flow with Aetna. It is now focused on cutting the costs of serving those patients with its HealthHubs.
Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
If Everything is Going Wrong for CVS Health Stock, is That a Buy Signal?
CVS Health has no shortage of risks. But a cheap valuation and long-term opportunities suggest the CVS stock sell-off has gone too far.
Should Debt Hold You Back From Buying CVS Stock? We’re Of Several Opinions
CVS Health added a lot of debt when it acquired Aetna for $69 billion. Should the company's balance sheet hold you back from buying CVS stock?
3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser
The stock charts of CVS Health, Pfizer and Weyerhaeuser head into the midpoint of the week on the verge of major moves.
CVS Stock Is Cheap for a Reason
CVS stock trades at a low multiple, and this will likely remain the case until management can restore confidence in CVS Health stock.
CVS Health Stock Has Cannibalized Itself
It seems like everywhere I go, there is a CVS. The company may have over-extended itself, which is bad news for CVS stock holders.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Aetna Uncertainty Is Keeping CVS Stock Way Undervalued
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
